Literature DB >> 21351813

Aztreonam lysine for inhalation solution in cystic fibrosis: profile report.

Greg L Plosker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21351813     DOI： 10.2165/11206940-000000000-00000

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


× No keyword cloud information.
  26 in total

1.  Inhaled antibiotics.

Authors:  Harm Tiddens
Journal:  Pediatr Pulmonol Suppl       Date:  2004

2.  Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis.

Authors:  Hartmut Grasemann; Fionn Kurtz; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2006-04-20       Impact factor: 21.405

3.  Tissue injury caused by deposition of immune complexes is L-arginine dependent.

Authors:  M S Mulligan; J M Hevel; M A Marletta; P A Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 4.  Cystic fibrosis.

Authors:  P B Davis; M Drumm; M W Konstan
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

5.  Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

Authors:  B W Ramsey; H L Dorkin; J D Eisenberg; R L Gibson; I R Harwood; R M Kravitz; D V Schidlow; R W Wilmott; S J Astley; M A McBurnie
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

Review 6.  Aerosol antibiotics in cystic fibrosis.

Authors:  David E Geller
Journal:  Respir Care       Date:  2009-05       Impact factor: 2.258

7.  Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis.

Authors:  George Z Retsch-Bogart; Alexandra L Quittner; Ronald L Gibson; Christopher M Oermann; Karen S McCoy; A Bruce Montgomery; Peter J Cooper
Journal:  Chest       Date:  2009-05       Impact factor: 9.410

Review 8.  The monobactams.

Authors:  N S Brewer; W C Hellinger
Journal:  Mayo Clin Proc       Date:  1991-11       Impact factor: 7.616

9.  A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis.

Authors:  M E Hodson; C G Gallagher; J R W Govan
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

10.  Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Karen S McCoy; Alexandra L Quittner; Christopher M Oermann; Ronald L Gibson; George Z Retsch-Bogart; A Bruce Montgomery
Journal:  Am J Respir Crit Care Med       Date:  2008-07-24       Impact factor: 21.405
View more
  1 in total

Review 1.  Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Authors:  M C Gaspar; W Couet; J-C Olivier; A A C C Pais; J J S Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.